2017 May 12
This $25,000 physical has found some ‘serious’ health problems. Others say it has serious problems.
Olivier Elemento, Ph.D., comments on a new kind of intensive health screening. Read more
2017 May 12
Utility of prognostic markers in CLL
Richard R. Furman, M.D., discusses the use of prognostic markers in the treatment of patients with chronic lymphocytic leukemia (CLL). Read more
2017 May 12
Increase in incidence of advanced prostate cancer
Jim C. Hu, M.D., discusses the increase in the incidence of advanced prostate cancer in the United States. Read more
2017 May 12
Intercampus collaboration enables graduate student scientists to learn from one another
Inter-campus collaborations have allowed graduate students to break new ground in computational biomedicine. Read more
2017 May 11
Stem cell transplant in ethnic populations
Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program discusses stem cell transplantation in patients of multi-ethnic populations who have hematologic malignancies. Read more
2017 May 10
SIRT6's ability to suppress cancer cell growth is explained
Ithaca affiliate Hening Lin, Ph.D., has elucidated the function of the SIRT6 proteins as tumor suppressors. Read more
2017 May 10
Ritchie reflects on research underway in Myeloproliferative Neoplasms
Ellen K. Ritchie, M.D., discusses the landscape of myeloproliferative neoplasms (MPNs). Read more
2017 May 10
Leonard highlights agents, approaches in pipeline for hematologic malignancies
John Leonard, M.D., discusses precision medicine, immunotherapy, CAR-T, and other emerging therapies in hematology. Read more
2017 May 10
Double-hit and double-expressor lymphomas
Sarah Rutherford, M.D., discusses the classification and prevalence of double-hit and double-expressor lymphomas. Read more
2017 May 10
Treating AYA patients with Hodgkin Lymphoma
Lisa Giulino Roth, M.D., discusses treating adolescent and young adult patients with Hodgkin lymphoma. Read more
2017 May 10
Midostaurin approval brings new hope in AML
Gail Roboz, M.D., discusses new and emerging treatments for acute myeloid leukemia (AML). Read more
2017 May 09
Using big data to make big strides in medicine
Christopher Mason, Ph.D., explains how a new initiative funded by WorldQuant founder Igor Tulchinsky will help medical researchers make better predictions. Read more
2017 May 09
Classifying T-cell lymphomas
Jia Ruan, M.D., Ph.D., discusses the classification of T-cell lymphomas. Read more
2017 May 09
Next steps in myeloma include combo regimens and achieving MRD
Ruben Niesvizky, M.D., discusses some of the exciting changes that have occurred in the field of multiple myeloma. Read more
2017 May 09
A 'stronger, more holistic' impact
Olivier Elemento, Ph.D., is featured in an article about Cornell's NYC connections. Read more
2017 May 08
Two Weill winners of Pershing Square Sohn Prize
Juan Cubillos-Ruiz and Yimon Aye were among six scientists selected as prestigious Pershing Square Sohn Prize winners. Read more
2017 May 05
New Method Developed to More Accurately Model Colorectal Cancer
Researchers have long struggled to develop preclinical models of colorectal cancer in which the disease forms in the correct anatomical location. Now Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center... Read more
2017 May 05
Patient preferences with MCL treatment
Peter Martin, M.D., assistant professor of medicine, discusses preferences patients have for treatment of their mantle cell lymphoma (MCL). Read more
2017 May 05
Emergence of CAR T-cell therapy in hematologic cancers
John P. Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies. Read more
